lunes, 30 de mayo de 2016

National Guideline Clearinghouse | Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.

National Guideline Clearinghouse | Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.



National Guideline Clearinghouse (NGC)

U.S. Preventive Services Task Force
Guideline Title
Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.
Bibliographic Source(s)
U.S. Preventive Services Task Force. Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement. JAMA. 2016 Feb 16;315(7):691-6. [22 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.
------



Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement. - PubMed - NCBI



 2016 Feb 16;315(7):691-6. doi: 10.1001/jama.2016.0018.

Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.

Abstract

DESCRIPTION:

New US Preventive Services Task Force (USPSTF) recommendation on screening for autism spectrum disorder (ASD) in young children.

METHODS:

The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of brief, formal screening instruments for ASD administered during routine primary care visits and the benefits and potential harms of early behavioral treatment for young children identified with ASD through screening.

POPULATION:

This recommendation applies to children aged 18 to 30 months who have not been diagnosed with ASD or developmental delay and for whom no concerns of ASD have been raised by parents, other caregivers, or health care professionals.

RECOMMENDATION:

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician. (I statement).

PMID:
 
26881372
 
[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario